A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Iannone, MD
AstraZeneca
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Beppu-shi, Japan
- Research Site
Chūōku, Japan
- Research Site
Kashiwa, Japan
- Research Site
Kitaadachi-gun, Japan
- Research Site
Kure-shi, Japan
- Research Site
Kōtoku, Japan
- Research Site
Matsuyama, Japan
- Research Site
Nagoya, Japan
- Research Site
Osaka, Japan
- Research Site
Sapporo, Japan
- Research Site
Sapporo, Japan
- Research Site
Sayama, Japan
- Research Site
Suita-shi, Japan
- Research Site
Sunto-gun, Japan
- Research Site
Takatsuki-shi, Japan
- Research Site
Yokohama, Japan
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Tainan, Taiwan
- Research Site
Taipei, Taiwan
- Research Site
Taoyuan, Taiwan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Sept 2013
- Primary completion
- 1 Mar 2018
- Completion
- 25 Nov 2020
- Last update posted
- 12 Mar 2021
- Registered enrollment
- 269
- Registry id
- NCT01938612
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.